(Q33237828)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Elisabeth Förster-Waldl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Holger Lode

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Erika Jensen-Jarolim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

4

Arnold Pollak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Kira H Brämswig

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Christoph C Zielinski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hubert Pehamberger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Otto Scheiner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1267-1274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16568495%20AND%20SRC:MED&resulttype=core&format=json

Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induce functional anti-carbohydrate antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

Tumor-Associated Carbohydrate Antigens Defining Tumor Malignancy: Basis for Development of Anti-Cancer Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Electrophysiological characteristics of primary afferent fibers after systemic administration of anti-GD2 ganglioside antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Isolation and structural analysis of peptide mimotopes for the disialoganglioside GD2, a neuroblastoma tumor antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Humoral immune response in disease-free advanced melanoma patients after vaccination with melanoma-associated gangliosides. EORTC Cooperative Melanoma Group

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Searching for Peptide Ligands with an Epitope Library

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Peptide ligands for a sugar-binding protein isolated from a random peptide library

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Antibody-selectable filamentous fd phage vectors: affinity purification of target genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Peptide mimicry of adenocarcinoma-associated carbohydrate antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021

DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535279

7 January 2021